Enliven Therapeutics, Inc. (ELVN)
NASDAQ: ELVN · Real-Time Price · USD
52.95
+0.14 (0.27%)
At close: Jul 24, 2026, 4:00 PM EDT
53.00
+0.05 (0.09%)
After-hours: Jul 24, 2026, 7:56 PM EDT
Enliven Therapeutics Market Cap
Enliven Therapeutics has a market cap or net worth of $3.7 billion as of July 24, 2026. Its market cap has increased by 237.11% in one year.
Market Cap
3.70B
Enterprise Value
3.25B
1-Year Change
237.11%
Ranking
Category
Stock Price
$52.95
ChartMarket Cap Chart
Since February 24, 2023, Enliven Therapeutics's market cap has increased from $974.02M to $3.70B, an increase of 279.57%. That is a compound annual growth rate of 47.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 3.70B | 304.52% |
| Dec 31, 2025 | 913.95M | -16.86% |
| Dec 31, 2024 | 1.10B | 92.74% |
| Dec 29, 2023 | 570.37M | -41.44% |
| Feb 24, 2023 | 974.02M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dyne Therapeutics | 3.97B |
| Parabilis Medicines | 3.93B |
| Tango Therapeutics | 3.89B |
| Denali Therapeutics | 3.62B |
| NewAmsterdam Pharma Company | 3.60B |
| Arcus Biosciences | 3.59B |
| Structure Therapeutics | 3.53B |
| Telix Pharmaceuticals | 3.47B |